Moxifloxacin Pregnancy

sponsored
How do you administer this medicine?

Pregnancy of Moxifloxacin in details

infoPregnancy is always a special situation where every action or side effect of the drug varies when compared to a situation of a non-pregnant patient. It is not only because the pregnant woman's metabolism differs due to the hormonal and other changes happened to her, but also because every medicine or its metabolite passes to the baby and shows its action there. The only thing is, be cautious, attentive and well supervised when you take any single drug in pregnancy. The interactions can vary in pregnancy, and the dosage may differ as well. Strict supervision of the Physician is mandatory.
sponsored

Animal studies have revealed evidence of fetotoxicity; no evidence of teratogenicity in rats (oral and IV doses) or cynomolgus monkeys (oral doses). In rats, reduced fetal weights, slightly delayed fetal skeletal development, maternal toxicity, and minor effects on placental weight and appearance were observed with oral doses (0.24 times the maximum recommended human dose [MRHD] based on AUC) or IV doses (about 2 times MRHD based on body surface area). In a pre- and postnatal development study in rats, slight increases in pregnancy duration and prenatal loss, reduced pup birth weight and neonatal survival, and therapy-related maternal mortality during gestation were observed with oral doses. In rabbits, reduced fetal weights, increased incidence (fetal and litter) of rib and vertebral malformations, delayed fetal skeletal ossification, increased incidence (fetal) of prominent liver lobulation, and maternal toxicity (including mortality, abortions, markedly reduced food consumption, reduced water intake, weight loss, hypoactivity) were observed with IV doses (about equal to oral MRHD based on AUC). In cynomolgus monkeys, increased incidence of smaller fetal size was observed with oral doses (2.5 times MRHD based on AUC). Animal studies suggest placental drug transfer. There are no controlled data in human pregnancy. Surveillance studies have not reported an increased risk of major birth defects with other quinolones; however, cartilage damage and arthropathies are reported in immature animals exposed to quinolones, giving rise to concern over effects on fetal bone formation. Of 549 cases reported by the European Network of Teratology Information Services involving exposure to other fluoroquinolones, congenital malformations were reported in 4.8%; however, this was not higher than the background rate. AU TGA pregnancy category B3: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

AU: Use is not recommended. UK: Use is contraindicated. US: This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. AU TGA pregnancy category: B3 US FDA pregnancy category: C Comments: Based on animal data, this drug may cause fetal harm.

Moxifloxacin breastfeeding

infoWhen a drug is taken when the patient is breast feeding, a part of the drug is secreted in her breast milk and is passed to the baby. The dosage of the medicine to mother and baby are different, and many drugs actions are side effects when you take them without a disease, and what if you the baby takes them without a disease? What if the drug is contraindicated in newborns, infants or children? So, breastfeeding is a very alarming situation when the mother is on medications. Ask your Physician or Pediatrician about the effect of the drug on the baby and how much is excreted in breast milk and if it harms the baby!
sponsored

This drug is presumed to be excreted in human milk. Traditionally, systemic fluoroquinolones have not been used in infants due to concern over toxic effects on their developing joints; however, some studies suggest risk is low. Absorption of the small amounts of fluoroquinolones in milk may be blocked by the calcium in milk; data insufficient to prove or disprove.

Use is considered acceptable; caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: -Maternal use of an ophthalmic drop containing this drug poses negligible risk for a nursing infant. -Placing pressure over the tear duct by the corner of the eye for at least 1 minute then removing excess solution with an absorbent tissue substantially reduces the amount of drug that reaches the breast milk after using eye drops.

References

  1. Human Metabolome Database (HMDB). "Moxifloxacin: The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.". http://www.hmdb.ca/metabolites/HMDB00143... (accessed September 18, 2017).
  2. FDA Pharm Classes. "FDA Pharmacological Classification: FDA published a final rule that amended the requirements for the content and format of approved labeling (prescribing information) for human prescription drug and biological products in January 2006.". https://www.fda.gov/ForIndustry/DataStan... (accessed September 18, 2017).

Reviews

Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 17 here

 
| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2017 ndrugs.com All Rights Reserved